nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—obesity	0.709	1	CbGaD
Icosapent ethyl—DGAT1—brown adipose tissue—obesity	0.0265	0.53	CbGeAlD
Icosapent ethyl—DGAT1—adrenal cortex—obesity	0.00444	0.0889	CbGeAlD
Icosapent ethyl—DGAT1—pituitary gland—obesity	0.00359	0.0719	CbGeAlD
Icosapent ethyl—DGAT1—adipose tissue—obesity	0.00357	0.0716	CbGeAlD
Icosapent ethyl—DGAT1—digestive system—obesity	0.00336	0.0674	CbGeAlD
Icosapent ethyl—DGAT1—adrenal gland—obesity	0.00321	0.0642	CbGeAlD
Icosapent ethyl—DGAT1—endocrine gland—obesity	0.00278	0.0557	CbGeAlD
Icosapent ethyl—DGAT1—liver—obesity	0.00251	0.0502	CbGeAlD
Icosapent ethyl—DGAT1—Triglyceride Biosynthesis—LPIN1—obesity	0.00138	0.0107	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—DGAT2—obesity	0.00137	0.0106	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—SCARB1—obesity	0.00134	0.0103	CbGpPWpGaD
Icosapent ethyl—Icosapent—PPARD—obesity	0.00132	0.258	CrCbGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RBP4—obesity	0.00119	0.00916	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—INPP5E—obesity	0.00116	0.00891	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—PNPLA2—obesity	0.0011	0.00846	CbGpPWpGaD
Icosapent ethyl—DGAT1—Triacylglyceride Synthesis—LPL—obesity	0.00103	0.00795	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PNPLA3—obesity	0.00101	0.00779	CbGpPWpGaD
Icosapent ethyl—Icosapent—FADS1—obesity	0.000999	0.195	CrCbGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—SCARB1—obesity	0.000979	0.00755	CbGpPWpGaD
Icosapent ethyl—Alpha-Linolenic Acid—FADS1—obesity	0.000976	0.191	CrCbGaD
Icosapent ethyl—DGAT1—Triglyceride Biosynthesis—FASN—obesity	0.000959	0.00739	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—DGAT2—obesity	0.000958	0.00738	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOB—obesity	0.000928	0.00715	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—LPL—obesity	0.000886	0.00683	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—CYP2E1—obesity	0.000869	0.0067	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ME1—obesity	0.000869	0.0067	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—GPAM—obesity	0.000857	0.0066	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—DGAT2—obesity	0.000774	0.00597	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PNPLA2—obesity	0.000766	0.0059	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOE—obesity	0.000743	0.00573	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—MUT—obesity	0.000739	0.00569	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—LPIN1—obesity	0.000736	0.00567	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOA1—obesity	0.000734	0.00566	CbGpPWpGaD
Icosapent ethyl—Icosapent—TRPV1—obesity	0.000693	0.135	CrCbGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ACLY—obesity	0.000682	0.00526	CbGpPWpGaD
Icosapent ethyl—Alpha-Linolenic Acid—TRPV1—obesity	0.000676	0.132	CrCbGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—LPL—obesity	0.000647	0.00498	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—HMGCS1—obesity	0.000638	0.00492	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ACADM—obesity	0.000619	0.00477	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ANGPTL4—obesity	0.000619	0.00477	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—CD36—obesity	0.000614	0.00474	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ACACB—obesity	0.000602	0.00464	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—obesity	0.000602	0.00464	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—GPAM—obesity	0.000598	0.00461	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARD—obesity	0.000548	0.00422	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—SLC27A1—obesity	0.000537	0.00414	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—LPIN1—obesity	0.000514	0.00396	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—BCHE—obesity	0.000508	0.00392	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ECHS1—obesity	0.000499	0.00385	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—GPAM—obesity	0.000483	0.00373	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ACSL1—obesity	0.000483	0.00373	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1B—obesity	0.000483	0.00373	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—obesity	0.000469	0.00362	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—HADH—obesity	0.000469	0.00362	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—SREBF2—obesity	0.000439	0.00339	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—LPIN1—obesity	0.000415	0.0032	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPM1L—obesity	0.000407	0.00314	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—INSIG2—obesity	0.000407	0.00314	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA5—obesity	0.000407	0.00314	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CLOCK—obesity	0.000388	0.00299	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—SULT2A1—obesity	0.000378	0.00292	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—INPP5E—obesity	0.000372	0.00287	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—BCHE—obesity	0.000354	0.00273	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ME1—obesity	0.000346	0.00267	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1A—obesity	0.000346	0.00267	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PNPLA3—obesity	0.000325	0.00251	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—DGAT2—obesity	0.000308	0.00238	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—SREBF1—obesity	0.000302	0.00233	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—MUT—obesity	0.000294	0.00227	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LIPE—obesity	0.000294	0.00227	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—obesity	0.000288	0.00222	CbGpPWpGaD
Icosapent ethyl—Insomnia—Diethylpropion—obesity	0.000274	0.00257	CcSEcCtD
Icosapent ethyl—Abdominal distension—Sibutramine—obesity	0.000273	0.00256	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ACLY—obesity	0.000271	0.00209	CbGpPWpGaD
Icosapent ethyl—Dysphagia—Sibutramine—obesity	0.000271	0.00254	CcSEcCtD
Icosapent ethyl—Influenza—Sibutramine—obesity	0.000271	0.00254	CcSEcCtD
Icosapent ethyl—Asthma—Sibutramine—obesity	0.000271	0.00254	CcSEcCtD
Icosapent ethyl—Dyspnoea—Diethylpropion—obesity	0.00027	0.00253	CcSEcCtD
Icosapent ethyl—Affect lability—Bupropion—obesity	0.000269	0.00252	CcSEcCtD
Icosapent ethyl—Migraine—Bupropion—obesity	0.000269	0.00252	CcSEcCtD
Icosapent ethyl—Dyspepsia—Diethylpropion—obesity	0.000267	0.0025	CcSEcCtD
Icosapent ethyl—Viral infection—Topiramate—obesity	0.000266	0.00249	CcSEcCtD
Icosapent ethyl—Angina pectoris—Sibutramine—obesity	0.000264	0.00248	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Cimetidine—obesity	0.000263	0.00246	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALOX12—obesity	0.000262	0.00202	CbGpPWpGaD
Icosapent ethyl—Gastrointestinal disorder—Diethylpropion—obesity	0.000262	0.00245	CcSEcCtD
Icosapent ethyl—Bronchitis—Sibutramine—obesity	0.000261	0.00244	CcSEcCtD
Icosapent ethyl—Constipation—Diethylpropion—obesity	0.000259	0.00243	CcSEcCtD
Icosapent ethyl—Mood swings—Bupropion—obesity	0.000259	0.00243	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HMGCS1—obesity	0.000254	0.00196	CbGpPWpGaD
Icosapent ethyl—Asthenia—Phentermine—obesity	0.00025	0.00234	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA1—obesity	0.00025	0.00193	CbGpPWpGaD
Icosapent ethyl—Feeling abnormal—Diethylpropion—obesity	0.00025	0.00234	CcSEcCtD
Icosapent ethyl—Infestation NOS—Orlistat—obesity	0.00025	0.00234	CcSEcCtD
Icosapent ethyl—Infestation—Orlistat—obesity	0.00025	0.00234	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Sibutramine—obesity	0.00025	0.00234	CcSEcCtD
Icosapent ethyl—Constipation—Cimetidine—obesity	0.000247	0.00231	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PNPLA2—obesity	0.000247	0.0019	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PLIN1—obesity	0.000247	0.0019	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ACADM—obesity	0.000247	0.0019	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ANGPTL4—obesity	0.000247	0.0019	CbGpPWpGaD
Icosapent ethyl—Hyperglycaemia—Sibutramine—obesity	0.000245	0.00229	CcSEcCtD
Icosapent ethyl—Pneumonia—Sibutramine—obesity	0.000243	0.00228	CcSEcCtD
Icosapent ethyl—Gastritis—Bupropion—obesity	0.000242	0.00227	CcSEcCtD
Icosapent ethyl—Dizziness—Phenylpropanolamine—obesity	0.000241	0.00226	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—OXCT1—obesity	0.00024	0.00185	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ACACB—obesity	0.00024	0.00185	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CA3—obesity	0.000239	0.00184	CbGpPWpGaD
Icosapent ethyl—Acute coronary syndrome—Sibutramine—obesity	0.000238	0.00223	CcSEcCtD
Icosapent ethyl—Abdominal distension—Bupropion—obesity	0.000238	0.00223	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Cimetidine—obesity	0.000238	0.00223	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Sibutramine—obesity	0.000237	0.00222	CcSEcCtD
Icosapent ethyl—Influenza—Bupropion—obesity	0.000236	0.00222	CcSEcCtD
Icosapent ethyl—Dysphagia—Bupropion—obesity	0.000236	0.00222	CcSEcCtD
Icosapent ethyl—Asthma—Bupropion—obesity	0.000236	0.00222	CcSEcCtD
Icosapent ethyl—Melaena—Topiramate—obesity	0.000234	0.0022	CcSEcCtD
Icosapent ethyl—Sinusitis—Orlistat—obesity	0.000234	0.0022	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PNLIP—obesity	0.000234	0.0018	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SRD5A1—obesity	0.000234	0.0018	CbGpPWpGaD
Icosapent ethyl—Sweating—Sibutramine—obesity	0.000232	0.00217	CcSEcCtD
Icosapent ethyl—Pancreatitis—Bupropion—obesity	0.000232	0.00217	CcSEcCtD
Icosapent ethyl—Vomiting—Phenylpropanolamine—obesity	0.000232	0.00217	CcSEcCtD
Icosapent ethyl—Dizziness—Phentermine—obesity	0.000231	0.00216	CcSEcCtD
Icosapent ethyl—Icosapent—PPARG—obesity	0.00023	0.045	CrCbGaD
Icosapent ethyl—Rash—Phenylpropanolamine—obesity	0.00023	0.00215	CcSEcCtD
Icosapent ethyl—Dermatitis—Phenylpropanolamine—obesity	0.000229	0.00215	CcSEcCtD
Icosapent ethyl—Body temperature increased—Cimetidine—obesity	0.000228	0.00214	CcSEcCtD
Icosapent ethyl—Epistaxis—Sibutramine—obesity	0.000228	0.00214	CcSEcCtD
Icosapent ethyl—Fluid retention—Topiramate—obesity	0.000228	0.00214	CcSEcCtD
Icosapent ethyl—Bronchitis—Bupropion—obesity	0.000227	0.00213	CcSEcCtD
Icosapent ethyl—Sinusitis—Sibutramine—obesity	0.000227	0.00213	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—obesity	0.000226	0.00174	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—STS—obesity	0.000223	0.00172	CbGpPWpGaD
Icosapent ethyl—Pharyngitis—Orlistat—obesity	0.000223	0.00209	CcSEcCtD
Icosapent ethyl—Vomiting—Phentermine—obesity	0.000222	0.00208	CcSEcCtD
Icosapent ethyl—Rash—Phentermine—obesity	0.00022	0.00206	CcSEcCtD
Icosapent ethyl—Dermatitis—Phentermine—obesity	0.00022	0.00206	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARD—obesity	0.000218	0.00168	CbGpPWpGaD
Icosapent ethyl—Erectile dysfunction—Bupropion—obesity	0.000218	0.00204	CcSEcCtD
Icosapent ethyl—Rhinitis—Sibutramine—obesity	0.000218	0.00204	CcSEcCtD
Icosapent ethyl—Neoplasm—Topiramate—obesity	0.000217	0.00203	CcSEcCtD
Icosapent ethyl—Pharyngitis—Sibutramine—obesity	0.000215	0.00202	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SLC27A1—obesity	0.000214	0.00165	CbGpPWpGaD
Icosapent ethyl—Hyperglycaemia—Bupropion—obesity	0.000213	0.002	CcSEcCtD
Icosapent ethyl—Pneumonia—Bupropion—obesity	0.000212	0.00199	CcSEcCtD
Icosapent ethyl—Infestation NOS—Bupropion—obesity	0.000211	0.00198	CcSEcCtD
Icosapent ethyl—Infestation—Bupropion—obesity	0.000211	0.00198	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—FABP4—obesity	0.00021	0.00162	CbGpPWpGaD
Icosapent ethyl—Acute coronary syndrome—Bupropion—obesity	0.000208	0.00195	CcSEcCtD
Icosapent ethyl—Asthenia—Cimetidine—obesity	0.000207	0.00194	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Bupropion—obesity	0.000207	0.00194	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Topiramate—obesity	0.000204	0.00191	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GLRX—obesity	0.000203	0.00157	CbGpPWpGaD
Icosapent ethyl—Sweating—Bupropion—obesity	0.000202	0.00189	CcSEcCtD
Icosapent ethyl—Dizziness—Diethylpropion—obesity	0.000201	0.00188	CcSEcCtD
Icosapent ethyl—Epistaxis—Bupropion—obesity	0.000199	0.00186	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ECHS1—obesity	0.000199	0.00153	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HSD11B1—obesity	0.000199	0.00153	CbGpPWpGaD
Icosapent ethyl—Alopecia—Orlistat—obesity	0.000198	0.00186	CcSEcCtD
Icosapent ethyl—Sinusitis—Bupropion—obesity	0.000198	0.00185	CcSEcCtD
Icosapent ethyl—Gastroenteritis—Topiramate—obesity	0.000197	0.00184	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—obesity	0.000195	0.00151	CbGpPWpGaD
Icosapent ethyl—Malnutrition—Orlistat—obesity	0.000195	0.00183	CcSEcCtD
Icosapent ethyl—Chills—Sibutramine—obesity	0.000195	0.00183	CcSEcCtD
Icosapent ethyl—Eczema—Topiramate—obesity	0.000194	0.00182	CcSEcCtD
Icosapent ethyl—Arrhythmia—Sibutramine—obesity	0.000194	0.00182	CcSEcCtD
Icosapent ethyl—Vomiting—Diethylpropion—obesity	0.000193	0.00181	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CG—obesity	0.000192	0.00148	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GPAM—obesity	0.000192	0.00148	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARGC1B—obesity	0.000192	0.00148	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ACSL1—obesity	0.000192	0.00148	CbGpPWpGaD
Icosapent ethyl—Alopecia—Sibutramine—obesity	0.000192	0.0018	CcSEcCtD
Icosapent ethyl—Rash—Diethylpropion—obesity	0.000191	0.00179	CcSEcCtD
Icosapent ethyl—Dysgeusia—Orlistat—obesity	0.000191	0.00179	CcSEcCtD
Icosapent ethyl—Dermatitis—Diethylpropion—obesity	0.000191	0.00179	CcSEcCtD
Icosapent ethyl—Dizziness—Cimetidine—obesity	0.000191	0.00179	CcSEcCtD
Icosapent ethyl—Rhinitis—Bupropion—obesity	0.00019	0.00178	CcSEcCtD
Icosapent ethyl—Malnutrition—Sibutramine—obesity	0.000189	0.00177	CcSEcCtD
Icosapent ethyl—Back pain—Orlistat—obesity	0.000189	0.00177	CcSEcCtD
Icosapent ethyl—Pharyngitis—Bupropion—obesity	0.000188	0.00176	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—FADS1—obesity	0.000187	0.00144	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HADH—obesity	0.000187	0.00144	CbGpPWpGaD
Icosapent ethyl—Increased appetite—Topiramate—obesity	0.000185	0.00174	CcSEcCtD
Icosapent ethyl—Dysgeusia—Sibutramine—obesity	0.000185	0.00173	CcSEcCtD
Icosapent ethyl—Vomiting—Cimetidine—obesity	0.000183	0.00172	CcSEcCtD
Icosapent ethyl—Back pain—Sibutramine—obesity	0.000183	0.00171	CcSEcCtD
Icosapent ethyl—Rash—Cimetidine—obesity	0.000182	0.00171	CcSEcCtD
Icosapent ethyl—Dermatitis—Cimetidine—obesity	0.000182	0.0017	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—obesity	0.000182	0.0014	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPM1L—obesity	0.000181	0.0014	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—INSIG2—obesity	0.000181	0.0014	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—OTC—obesity	0.000181	0.0014	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ETFDH—obesity	0.000181	0.0014	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Orlistat—obesity	0.000181	0.0017	CcSEcCtD
Icosapent ethyl—Malaise—Orlistat—obesity	0.000176	0.00165	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—obesity	0.000176	0.00136	CbGpPWpGaD
Icosapent ethyl—Vertigo—Orlistat—obesity	0.000175	0.00164	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Sibutramine—obesity	0.000175	0.00164	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SREBF2—obesity	0.000175	0.00135	CbGpPWpGaD
Icosapent ethyl—Affect lability—Topiramate—obesity	0.000172	0.00161	CcSEcCtD
Icosapent ethyl—Migraine—Topiramate—obesity	0.000172	0.00161	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—obesity	0.00017	0.00131	CbGpPWpGaD
Icosapent ethyl—Malaise—Sibutramine—obesity	0.00017	0.0016	CcSEcCtD
Icosapent ethyl—Cough—Orlistat—obesity	0.00017	0.0016	CcSEcCtD
Icosapent ethyl—Chills—Bupropion—obesity	0.00017	0.00159	CcSEcCtD
Icosapent ethyl—Vertigo—Sibutramine—obesity	0.00017	0.00159	CcSEcCtD
Icosapent ethyl—Syncope—Sibutramine—obesity	0.000169	0.00159	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CD—obesity	0.000169	0.0013	CbGpPWpGaD
Icosapent ethyl—Arrhythmia—Bupropion—obesity	0.000169	0.00158	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LPA—obesity	0.000169	0.0013	CbGpPWpGaD
Icosapent ethyl—Alopecia—Bupropion—obesity	0.000167	0.00157	CcSEcCtD
Icosapent ethyl—Myalgia—Orlistat—obesity	0.000166	0.00156	CcSEcCtD
Icosapent ethyl—Chest pain—Orlistat—obesity	0.000166	0.00156	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Sibutramine—obesity	0.000166	0.00156	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GPT—obesity	0.000166	0.00128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UQCRC2—obesity	0.000166	0.00128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—INPP5E—obesity	0.000166	0.00128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LPIN1—obesity	0.000165	0.00127	CbGpPWpGaD
Icosapent ethyl—Mood swings—Topiramate—obesity	0.000165	0.00155	CcSEcCtD
Icosapent ethyl—Cough—Sibutramine—obesity	0.000165	0.00155	CcSEcCtD
Icosapent ethyl—Malnutrition—Bupropion—obesity	0.000165	0.00154	CcSEcCtD
Icosapent ethyl—Discomfort—Orlistat—obesity	0.000164	0.00154	CcSEcCtD
Icosapent ethyl—Hypertension—Sibutramine—obesity	0.000163	0.00153	CcSEcCtD
Icosapent ethyl—Dry mouth—Orlistat—obesity	0.000163	0.00152	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOA5—obesity	0.000162	0.00125	CbGpPWpGaD
Icosapent ethyl—Dysgeusia—Bupropion—obesity	0.000161	0.00151	CcSEcCtD
Icosapent ethyl—Myalgia—Sibutramine—obesity	0.000161	0.00151	CcSEcCtD
Icosapent ethyl—Arthralgia—Sibutramine—obesity	0.000161	0.00151	CcSEcCtD
Icosapent ethyl—Chest pain—Sibutramine—obesity	0.000161	0.00151	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3R1—obesity	0.00016	0.00123	CbGpPWpGaD
Icosapent ethyl—Oedema—Orlistat—obesity	0.000159	0.00149	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Orlistat—obesity	0.000159	0.00149	CcSEcCtD
Icosapent ethyl—Back pain—Bupropion—obesity	0.000159	0.00149	CcSEcCtD
Icosapent ethyl—Discomfort—Sibutramine—obesity	0.000159	0.00149	CcSEcCtD
Icosapent ethyl—Infection—Orlistat—obesity	0.000158	0.00148	CcSEcCtD
Icosapent ethyl—Dry mouth—Sibutramine—obesity	0.000157	0.00147	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Topiramate—obesity	0.000157	0.00147	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CLOCK—obesity	0.000155	0.00119	CbGpPWpGaD
Icosapent ethyl—Gastritis—Topiramate—obesity	0.000154	0.00145	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Sibutramine—obesity	0.000154	0.00145	CcSEcCtD
Icosapent ethyl—Oedema—Sibutramine—obesity	0.000154	0.00145	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ALDH6A1—obesity	0.000154	0.00119	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ME1—obesity	0.000154	0.00119	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SUCLG2—obesity	0.000154	0.00119	CbGpPWpGaD
Icosapent ethyl—Hyperhidrosis—Orlistat—obesity	0.000154	0.00144	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Topiramate—obesity	0.000154	0.00144	CcSEcCtD
Icosapent ethyl—Infection—Sibutramine—obesity	0.000153	0.00144	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Bupropion—obesity	0.000153	0.00143	CcSEcCtD
Icosapent ethyl—Shock—Sibutramine—obesity	0.000152	0.00142	CcSEcCtD
Icosapent ethyl—Abdominal distension—Topiramate—obesity	0.000152	0.00142	CcSEcCtD
Icosapent ethyl—Asthma—Topiramate—obesity	0.000151	0.00141	CcSEcCtD
Icosapent ethyl—Dysphagia—Topiramate—obesity	0.000151	0.00141	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SULT2A1—obesity	0.000151	0.00116	CbGpPWpGaD
Icosapent ethyl—Tachycardia—Sibutramine—obesity	0.00015	0.00141	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—obesity	0.00015	0.00116	CbGpPWpGaD
Icosapent ethyl—Hyperhidrosis—Sibutramine—obesity	0.000149	0.0014	CcSEcCtD
Icosapent ethyl—Malaise—Bupropion—obesity	0.000149	0.00139	CcSEcCtD
Icosapent ethyl—Vertigo—Bupropion—obesity	0.000148	0.00139	CcSEcCtD
Icosapent ethyl—Syncope—Bupropion—obesity	0.000148	0.00138	CcSEcCtD
Icosapent ethyl—Pancreatitis—Topiramate—obesity	0.000148	0.00138	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CB—obesity	0.000147	0.00114	CbGpPWpGaD
Icosapent ethyl—Anorexia—Sibutramine—obesity	0.000147	0.00138	CcSEcCtD
Icosapent ethyl—Angina pectoris—Topiramate—obesity	0.000147	0.00138	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Orlistat—obesity	0.000145	0.00136	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—COX7C—obesity	0.000145	0.00112	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UCP1—obesity	0.000145	0.00112	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PNPLA3—obesity	0.000145	0.00112	CbGpPWpGaD
Icosapent ethyl—Bronchitis—Topiramate—obesity	0.000145	0.00136	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Bupropion—obesity	0.000145	0.00136	CcSEcCtD
Icosapent ethyl—Insomnia—Orlistat—obesity	0.000144	0.00135	CcSEcCtD
Icosapent ethyl—Cough—Bupropion—obesity	0.000144	0.00135	CcSEcCtD
Icosapent ethyl—Hypertension—Bupropion—obesity	0.000142	0.00133	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Sibutramine—obesity	0.00014	0.00132	CcSEcCtD
Icosapent ethyl—Dyspepsia—Orlistat—obesity	0.00014	0.00131	CcSEcCtD
Icosapent ethyl—Chest pain—Bupropion—obesity	0.00014	0.00131	CcSEcCtD
Icosapent ethyl—Myalgia—Bupropion—obesity	0.00014	0.00131	CcSEcCtD
Icosapent ethyl—Arthralgia—Bupropion—obesity	0.00014	0.00131	CcSEcCtD
Icosapent ethyl—Insomnia—Sibutramine—obesity	0.000139	0.00131	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Topiramate—obesity	0.000139	0.0013	CcSEcCtD
Icosapent ethyl—Discomfort—Bupropion—obesity	0.000139	0.0013	CcSEcCtD
Icosapent ethyl—Decreased appetite—Orlistat—obesity	0.000138	0.0013	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CPT1A—obesity	0.000138	0.00106	CbGpPWpGaD
Icosapent ethyl—Gastrointestinal disorder—Orlistat—obesity	0.000138	0.00129	CcSEcCtD
Icosapent ethyl—Dyspnoea—Sibutramine—obesity	0.000137	0.00129	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CS—obesity	0.000137	0.00106	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—DGAT2—obesity	0.000137	0.00106	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CPS1—obesity	0.000137	0.00106	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SUCLA2—obesity	0.000137	0.00106	CbGpPWpGaD
Icosapent ethyl—Dry mouth—Bupropion—obesity	0.000137	0.00129	CcSEcCtD
Icosapent ethyl—Pain—Orlistat—obesity	0.000136	0.00128	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Topiramate—obesity	0.000136	0.00127	CcSEcCtD
Icosapent ethyl—Dyspepsia—Sibutramine—obesity	0.000136	0.00127	CcSEcCtD
Icosapent ethyl—Pneumonia—Topiramate—obesity	0.000135	0.00127	CcSEcCtD
Icosapent ethyl—Oedema—Bupropion—obesity	0.000134	0.00126	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Bupropion—obesity	0.000134	0.00126	CcSEcCtD
Icosapent ethyl—Infestation—Topiramate—obesity	0.000134	0.00126	CcSEcCtD
Icosapent ethyl—Infestation NOS—Topiramate—obesity	0.000134	0.00126	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LIPC—obesity	0.000134	0.00103	CbGpPWpGaD
Icosapent ethyl—Decreased appetite—Sibutramine—obesity	0.000134	0.00126	CcSEcCtD
Icosapent ethyl—Infection—Bupropion—obesity	0.000134	0.00125	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOC3—obesity	0.000133	0.00103	CbGpPWpGaD
Icosapent ethyl—Gastrointestinal disorder—Sibutramine—obesity	0.000133	0.00125	CcSEcCtD
Icosapent ethyl—Shock—Bupropion—obesity	0.000132	0.00124	CcSEcCtD
Icosapent ethyl—Constipation—Sibutramine—obesity	0.000132	0.00124	CcSEcCtD
Icosapent ethyl—Pain—Sibutramine—obesity	0.000132	0.00124	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Orlistat—obesity	0.000131	0.00123	CcSEcCtD
Icosapent ethyl—Tachycardia—Bupropion—obesity	0.000131	0.00123	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—LIPE—obesity	0.000131	0.00101	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MUT—obesity	0.000131	0.00101	CbGpPWpGaD
Icosapent ethyl—Hyperhidrosis—Bupropion—obesity	0.00013	0.00122	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CETP—obesity	0.000129	0.000998	CbGpPWpGaD
Icosapent ethyl—Anorexia—Bupropion—obesity	0.000128	0.0012	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SDC1—obesity	0.000128	0.000987	CbGpPWpGaD
Icosapent ethyl—Feeling abnormal—Sibutramine—obesity	0.000127	0.00119	CcSEcCtD
Icosapent ethyl—Epistaxis—Topiramate—obesity	0.000127	0.00119	CcSEcCtD
Icosapent ethyl—Sinusitis—Topiramate—obesity	0.000126	0.00118	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—AKR1C3—obesity	0.000126	0.000971	CbGpPWpGaD
Icosapent ethyl—Body temperature increased—Orlistat—obesity	0.000126	0.00118	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CYB5A—obesity	0.000126	0.000968	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SCARB1—obesity	0.000124	0.000956	CbGpPWpGaD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—obesity	0.000124	0.0242	CrCbGaD
Icosapent ethyl—Musculoskeletal discomfort—Bupropion—obesity	0.000122	0.00115	CcSEcCtD
Icosapent ethyl—Body temperature increased—Sibutramine—obesity	0.000122	0.00114	CcSEcCtD
Icosapent ethyl—Insomnia—Bupropion—obesity	0.000122	0.00114	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ACLY—obesity	0.000121	0.000932	CbGpPWpGaD
Icosapent ethyl—Rhinitis—Topiramate—obesity	0.000121	0.00113	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SREBF1—obesity	0.00012	0.000928	CbGpPWpGaD
Icosapent ethyl—Dyspnoea—Bupropion—obesity	0.00012	0.00112	CcSEcCtD
Icosapent ethyl—Pharyngitis—Topiramate—obesity	0.00012	0.00112	CcSEcCtD
Icosapent ethyl—Dyspepsia—Bupropion—obesity	0.000118	0.00111	CcSEcCtD
Icosapent ethyl—Decreased appetite—Bupropion—obesity	0.000117	0.0011	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ENPP1—obesity	0.000117	0.0009	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALOX12—obesity	0.000117	0.0009	CbGpPWpGaD
Icosapent ethyl—Gastrointestinal disorder—Bupropion—obesity	0.000116	0.00109	CcSEcCtD
Icosapent ethyl—Constipation—Bupropion—obesity	0.000115	0.00108	CcSEcCtD
Icosapent ethyl—Pain—Bupropion—obesity	0.000115	0.00108	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—FASN—obesity	0.000115	0.000884	CbGpPWpGaD
Icosapent ethyl—Asthenia—Orlistat—obesity	0.000114	0.00107	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—BCHE—obesity	0.000114	0.00088	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HMGCS1—obesity	0.000113	0.000872	CbGpPWpGaD
Icosapent ethyl—Pruritus—Orlistat—obesity	0.000113	0.00106	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Bupropion—obesity	0.000111	0.00104	CcSEcCtD
Icosapent ethyl—Asthenia—Sibutramine—obesity	0.000111	0.00104	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ANGPTL4—obesity	0.00011	0.000846	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PNPLA2—obesity	0.00011	0.000846	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SAT1—obesity	0.00011	0.000846	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PLIN1—obesity	0.00011	0.000846	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PFKFB3—obesity	0.00011	0.000846	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ACADM—obesity	0.00011	0.000846	CbGpPWpGaD
Icosapent ethyl—Pruritus—Sibutramine—obesity	0.000109	0.00102	CcSEcCtD
Icosapent ethyl—Chills—Topiramate—obesity	0.000108	0.00101	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CYTB—obesity	0.000107	0.000823	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ACACB—obesity	0.000107	0.000823	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—OXCT1—obesity	0.000107	0.000823	CbGpPWpGaD
Icosapent ethyl—Alopecia—Topiramate—obesity	0.000107	0.000999	CcSEcCtD
Icosapent ethyl—Body temperature increased—Bupropion—obesity	0.000106	0.000996	CcSEcCtD
Icosapent ethyl—Dizziness—Orlistat—obesity	0.000105	0.000988	CcSEcCtD
Icosapent ethyl—Malnutrition—Topiramate—obesity	0.000105	0.000984	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PNLIP—obesity	0.000104	0.000802	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SRD5A1—obesity	0.000104	0.000802	CbGpPWpGaD
Icosapent ethyl—Dysgeusia—Topiramate—obesity	0.000103	0.000963	CcSEcCtD
Icosapent ethyl—Dizziness—Sibutramine—obesity	0.000102	0.000956	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—SDC3—obesity	0.000102	0.000783	CbGpPWpGaD
Icosapent ethyl—Back pain—Topiramate—obesity	0.000101	0.000951	CcSEcCtD
Icosapent ethyl—Vomiting—Orlistat—obesity	0.000101	0.00095	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GGT1—obesity	0.000101	0.000779	CbGpPWpGaD
Icosapent ethyl—Rash—Orlistat—obesity	0.0001	0.000942	CcSEcCtD
Icosapent ethyl—Dermatitis—Orlistat—obesity	0.0001	0.000941	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOA1—obesity	9.96e-05	0.000768	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP26B1—obesity	9.93e-05	0.000765	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HK2—obesity	9.93e-05	0.000765	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—STS—obesity	9.93e-05	0.000765	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP19A1—obesity	9.81e-05	0.000757	CbGpPWpGaD
Icosapent ethyl—Vomiting—Sibutramine—obesity	9.8e-05	0.000919	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Topiramate—obesity	9.74e-05	0.000913	CcSEcCtD
Icosapent ethyl—Rash—Sibutramine—obesity	9.72e-05	0.000911	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PPARD—obesity	9.72e-05	0.000749	CbGpPWpGaD
Icosapent ethyl—Dermatitis—Sibutramine—obesity	9.71e-05	0.000911	CcSEcCtD
Icosapent ethyl—Icosapent—PTGS2—obesity	9.71e-05	0.019	CrCbGaD
Icosapent ethyl—Asthenia—Bupropion—obesity	9.64e-05	0.000904	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—SLC27A1—obesity	9.52e-05	0.000734	CbGpPWpGaD
Icosapent ethyl—Pruritus—Bupropion—obesity	9.51e-05	0.000891	CcSEcCtD
Icosapent ethyl—Malaise—Topiramate—obesity	9.46e-05	0.000887	CcSEcCtD
Icosapent ethyl—Vertigo—Topiramate—obesity	9.43e-05	0.000884	CcSEcCtD
Icosapent ethyl—Syncope—Topiramate—obesity	9.41e-05	0.000882	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GLUL—obesity	9.33e-05	0.00072	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—FABP4—obesity	9.33e-05	0.00072	CbGpPWpGaD
Icosapent ethyl—Loss of consciousness—Topiramate—obesity	9.22e-05	0.000865	CcSEcCtD
Icosapent ethyl—Cough—Topiramate—obesity	9.16e-05	0.000858	CcSEcCtD
Icosapent ethyl—Hypertension—Topiramate—obesity	9.06e-05	0.000849	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	9e-05	0.000694	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CA—obesity	8.99e-05	0.000693	CbGpPWpGaD
Icosapent ethyl—Arthralgia—Topiramate—obesity	8.93e-05	0.000837	CcSEcCtD
Icosapent ethyl—Chest pain—Topiramate—obesity	8.93e-05	0.000837	CcSEcCtD
Icosapent ethyl—Myalgia—Topiramate—obesity	8.93e-05	0.000837	CcSEcCtD
Icosapent ethyl—Dizziness—Bupropion—obesity	8.89e-05	0.000833	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—HSD11B1—obesity	8.85e-05	0.000682	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UCP2—obesity	8.85e-05	0.000682	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UCP3—obesity	8.85e-05	0.000682	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ECHS1—obesity	8.85e-05	0.000682	CbGpPWpGaD
Icosapent ethyl—Discomfort—Topiramate—obesity	8.83e-05	0.000827	CcSEcCtD
Icosapent ethyl—Dry mouth—Topiramate—obesity	8.74e-05	0.000819	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ADH1B—obesity	8.71e-05	0.000671	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOB—obesity	8.58e-05	0.000661	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ACSL1—obesity	8.57e-05	0.000661	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GPAM—obesity	8.57e-05	0.000661	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPARGC1B—obesity	8.57e-05	0.000661	CbGpPWpGaD
Icosapent ethyl—Oedema—Topiramate—obesity	8.56e-05	0.000803	CcSEcCtD
Icosapent ethyl—Vomiting—Bupropion—obesity	8.55e-05	0.000801	CcSEcCtD
Icosapent ethyl—Infection—Topiramate—obesity	8.51e-05	0.000798	CcSEcCtD
Icosapent ethyl—Rash—Bupropion—obesity	8.48e-05	0.000794	CcSEcCtD
Icosapent ethyl—Dermatitis—Bupropion—obesity	8.47e-05	0.000794	CcSEcCtD
Icosapent ethyl—Shock—Topiramate—obesity	8.43e-05	0.00079	CcSEcCtD
Icosapent ethyl—Tachycardia—Topiramate—obesity	8.36e-05	0.000784	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—FADS1—obesity	8.32e-05	0.000641	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PCK1—obesity	8.32e-05	0.000641	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HADH—obesity	8.32e-05	0.000641	CbGpPWpGaD
Icosapent ethyl—Hyperhidrosis—Topiramate—obesity	8.28e-05	0.000776	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LPL—obesity	8.19e-05	0.000631	CbGpPWpGaD
Icosapent ethyl—Anorexia—Topiramate—obesity	8.16e-05	0.000765	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ACP5—obesity	8.09e-05	0.000624	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GPX1—obesity	7.99e-05	0.000616	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—G6PD—obesity	7.89e-05	0.000608	CbGpPWpGaD
Icosapent ethyl—Musculoskeletal discomfort—Topiramate—obesity	7.8e-05	0.000731	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—HK1—obesity	7.79e-05	0.000601	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SREBF2—obesity	7.79e-05	0.000601	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CD36—obesity	7.78e-05	0.0006	CbGpPWpGaD
Icosapent ethyl—Insomnia—Topiramate—obesity	7.75e-05	0.000726	CcSEcCtD
Icosapent ethyl—Dyspnoea—Topiramate—obesity	7.63e-05	0.000716	CcSEcCtD
Icosapent ethyl—Dyspepsia—Topiramate—obesity	7.54e-05	0.000707	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—LPA—obesity	7.52e-05	0.00058	CbGpPWpGaD
Icosapent ethyl—Decreased appetite—Topiramate—obesity	7.44e-05	0.000698	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Topiramate—obesity	7.39e-05	0.000693	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—LPIN1—obesity	7.36e-05	0.000568	CbGpPWpGaD
Icosapent ethyl—Pain—Topiramate—obesity	7.32e-05	0.000687	CcSEcCtD
Icosapent ethyl—Constipation—Topiramate—obesity	7.32e-05	0.000687	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARA—obesity	7.24e-05	0.000558	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOA5—obesity	7.21e-05	0.000556	CbGpPWpGaD
Icosapent ethyl—Feeling abnormal—Topiramate—obesity	7.06e-05	0.000662	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—AGT—obesity	7.01e-05	0.00054	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC22A1—obesity	6.88e-05	0.000531	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CLOCK—obesity	6.88e-05	0.000531	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOE—obesity	6.87e-05	0.000529	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CAV1—obesity	6.8e-05	0.000524	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOA1—obesity	6.79e-05	0.000523	CbGpPWpGaD
Icosapent ethyl—Body temperature increased—Topiramate—obesity	6.77e-05	0.000635	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—SULT2A1—obesity	6.71e-05	0.000517	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GLP1R—obesity	6.71e-05	0.000517	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—DPYD—obesity	6.6e-05	0.000509	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PRKAR2B—obesity	6.35e-05	0.00049	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—DCN—obesity	6.31e-05	0.000486	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CG—obesity	6.2e-05	0.000478	CbGpPWpGaD
Icosapent ethyl—Asthenia—Topiramate—obesity	6.14e-05	0.000576	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CPT1A—obesity	6.13e-05	0.000473	CbGpPWpGaD
Icosapent ethyl—Pruritus—Topiramate—obesity	6.06e-05	0.000568	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—NAMPT—obesity	6.02e-05	0.000464	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARG—obesity	5.98e-05	0.000461	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LIPC—obesity	5.98e-05	0.000461	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GCK—obesity	5.98e-05	0.000461	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOC3—obesity	5.94e-05	0.000458	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—POMC—obesity	5.9e-05	0.000455	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CETP—obesity	5.77e-05	0.000445	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SDC1—obesity	5.7e-05	0.00044	CbGpPWpGaD
Icosapent ethyl—Dizziness—Topiramate—obesity	5.66e-05	0.000531	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—AKR1C3—obesity	5.61e-05	0.000432	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SCARB1—obesity	5.52e-05	0.000426	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	5.45e-05	0.00042	CbGpPWpGaD
Icosapent ethyl—Vomiting—Topiramate—obesity	5.44e-05	0.00051	CcSEcCtD
Icosapent ethyl—Rash—Topiramate—obesity	5.4e-05	0.000506	CcSEcCtD
Icosapent ethyl—Dermatitis—Topiramate—obesity	5.39e-05	0.000506	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALB—obesity	5.38e-05	0.000415	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SREBF1—obesity	5.36e-05	0.000413	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GOT2—obesity	5.22e-05	0.000402	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	5.14e-05	0.000397	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—FASN—obesity	5.1e-05	0.000393	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—BCHE—obesity	5.08e-05	0.000392	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP2E1—obesity	4.9e-05	0.000378	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NQO1—obesity	4.85e-05	0.000374	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.75e-05	0.000366	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.7e-05	0.000363	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC2A4—obesity	4.65e-05	0.000358	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GCG—obesity	4.65e-05	0.000358	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYCS—obesity	4.59e-05	0.000354	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GGT1—obesity	4.5e-05	0.000347	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GOT1—obesity	4.5e-05	0.000347	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOA1—obesity	4.43e-05	0.000342	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—STK11—obesity	4.37e-05	0.000337	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP19A1—obesity	4.37e-05	0.000337	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—COMT—obesity	4.06e-05	0.000313	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GNB3—obesity	4.01e-05	0.000309	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPARGC1A—obesity	4.01e-05	0.000309	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HMOX1—obesity	3.99e-05	0.000307	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GNAS—obesity	3.9e-05	0.000301	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOB—obesity	3.82e-05	0.000295	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LPL—obesity	3.65e-05	0.000281	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GPX1—obesity	3.56e-05	0.000274	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CD36—obesity	3.47e-05	0.000267	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MTHFR—obesity	3.28e-05	0.000253	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPARA—obesity	3.22e-05	0.000248	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AGT—obesity	3.12e-05	0.000241	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOE—obesity	3.06e-05	0.000236	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CAV1—obesity	3.03e-05	0.000234	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOA1—obesity	3.02e-05	0.000233	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.89e-05	0.000223	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CG—obesity	2.76e-05	0.000213	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPARG—obesity	2.66e-05	0.000205	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—POMC—obesity	2.63e-05	0.000202	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—INS—obesity	2.61e-05	0.000201	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CD—obesity	2.43e-05	0.000187	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALB—obesity	2.39e-05	0.000185	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3R1—obesity	2.29e-05	0.000177	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NOS3—obesity	2.29e-05	0.000177	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CB—obesity	2.11e-05	0.000163	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PTGS2—obesity	2.1e-05	0.000162	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CA—obesity	1.29e-05	9.94e-05	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AKT1—obesity	1.05e-05	8.12e-05	CbGpPWpGaD
